Schedule
of disaggregated cost of revenue and research and development
| | |
2025 | | |
2026 | |
| | |
For the six months ended June 30, | |
| | |
2025 | | |
2026 | |
| | |
(RMB in thousands) | |
| Cost of revenue (excluding the impact of write-down) | |
| 35,170 | | |
| 7,735 | |
| Inventory provision, write-down of prepayments and provision for inventory purchase commitments | |
| 54,782 | | |
| 14,332 | |
| Total cost of revenue | |
| 89,952 | | |
| 22,067 | |
| Salary, bonus, welfare and share-based compensation expense | |
| 21,645 | | |
| 16,225 | |
| New products development | |
| 18,134 | | |
| 4,907 | |
| Depreciation | |
| 1,813 | | |
| 1,223 | |
| Total research and development expenses | |
| 41,592 | | |
| 22,355 | |
|